Page last updated: 2024-09-03

phenylalanyl-prolyl-arginine-chloromethyl ketone and Deep Vein Thrombosis

phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with Deep Vein Thrombosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hollenbach, SJ; Ku, P; Lin, PH; Malinowski, J; Marlowe, CK; Scarborough, RM; Sinha, U; Wong, PW; Zhu, BY1

Other Studies

1 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and Deep Vein Thrombosis

ArticleYear
Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
    European journal of pharmacology, 2000, Apr-21, Volume: 395, Issue:1

    Topics: Amino Acid Chloromethyl Ketones; Animals; Anticoagulants; Antithrombins; Arteriovenous Shunt, Surgical; Bleeding Time; Disease Models, Animal; Dose-Response Relationship, Drug; Enoxaparin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemostatics; Heparin; Male; Oligopeptides; Rabbits; Serine Proteinase Inhibitors; Thiazoles; Thrombin; Thrombosis; Venous Thrombosis

2000